Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Jul 12;24(1):142-50.
doi: 10.1016/j.cmet.2016.05.012. Epub 2016 Jun 16.

The Adipose Tissue Microenvironment Regulates Depot-Specific Adipogenesis in Obesity

Affiliations

The Adipose Tissue Microenvironment Regulates Depot-Specific Adipogenesis in Obesity

Elise Jeffery et al. Cell Metab. .

Abstract

The sexually dimorphic distribution of adipose tissue influences the development of obesity-associated pathologies. The accumulation of visceral white adipose tissue (VWAT) that occurs in males is detrimental to metabolic health, while accumulation of subcutaneous adipose tissue (SWAT) seen in females may be protective. Here, we show that adipocyte hyperplasia contributes directly to the differential fat distribution between the sexes. In male mice, high-fat diet (HFD) induces adipogenesis specifically in VWAT, while in females HFD induces adipogenesis in both VWAT and SWAT in a sex hormone-dependent manner. We also show that the activation of adipocyte precursors (APs), which drives adipocyte hyperplasia in obesity, is regulated by the adipose depot microenvironment and not by cell-intrinsic mechanisms. These findings indicate that APs are plastic cells, which respond to both local and systemic signals that influence their differentiation potential independent of depot origin. Therefore, depot-specific AP niches coordinate adipose tissue growth and distribution.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Adipocyte hyperplasia contributes to depot- and sex-specific WAT growth in obesity
(A) Body fat as a percentage of total body weight after 8 weeks of SD or HFD feeding in male and female C57Bl/6J Adiponectin-creER; mTmG mice as measured by magnetic resonance imaging. (B) Weight of individual fat pads from male or female C57Bl/6J Adiponectin-creER; mTmG mice after 8 weeks of SD or HFD feeding. (In A and B, n = 9–15) (C) Experimental design for Adiponectin-creER; mTmG adipogenesis experiments. (D–E) Representative confocal images (left) and quantification (right) of adipocyte labeling in the indicated depots of Adiponectin-creER; mTmG male (D) or female (E) mice. (Males: n = 4–6. Females: n = 12–15) (F–G) Average adipocyte diameter of tdTomato+ (new) and eGFP+ (old) adipocytes from the indicated groups. (n = 4–6) Note: all data from A-E are from tamoxifen-treated animals. Significance was determined by comparing the indicated groups using an unpaired two-tailed student’s t-test. Scale bar is 100μM. Error bars represent mean ± S.E.M. See also Figure S1.
Figure 2
Figure 2. Fat pad weight and adipocyte precursor activation mirror depot-specific patterns of adipogenesis
(A–D) Correlation between adipogenesis and fat pad weight in the indicated depots of male (AB) or female (C–D) mice. Each point represents one mouse. (n = 21–26) (E) Representative flow cytometry plots to measure BrdU incorporation into adipocyte precursors. (F) BrdU incorporation into APs from the indicated depot of female mice following one week of SD or HFD and BrdU treatment. (n = 5 per group) (G) BrdU incorporation into adipocyte nuclei as measured via immunofluorescence in paraffin sections following one week of BrdU treatment (pulse) and 7 more weeks of the indicated diet (chase). (n = 8–10) (H–I) BrdU incorporation into APs from the indicated depot of ovariectomized female (H) or estrogen-treated male (I) mice following one week of SD or HFD and BrdU treatment. (n = 5–10) Significance in A–D was determined using Spearman’s non-parametric two-tailed correlation analysis. Significance in F–I was determined by comparing the indicated groups using an unpaired two-tailed student’s t-test. Error bars represent mean ± S.E.M. See also Figure S2.
Figure 3
Figure 3. Adipocyte precursor activation at the onset of obesity is determined by the adipose depot microenvironment
(A) Experimental design for AP transplant experiment. (B–C) Representative flow cytometry histogram (B) and dot plot (C) demonstrating engraftment of donor-derived tdTomato+ APs in the recipient depot, and BrdU incorporation into both tdTomato− and tdTomato+ populations. (D–E) BrdU incorporation into APs in donor, endogenous, or contralateral populations after 1 week of the indicated diet and BrdU treatment. (n = 3–8) Astrisks indicate significance over SD controls. Significance was determined using one-way ANOVA. Error bars represent mean ± S.E.M. See also Figure S3.
Figure 4
Figure 4. High-fat diet induced adipogenesis of adipocyte precursors is determined by the adipose depot microenvironment
(A) Experimental design for AP transplant experiment. (B) Representative images of mice with luminescent signal overlay following luciferase injection at the indicated time following transplant of APs from the SWAT of leptin-luciferase; mTmG mice. (C) Quantification of luminescent signal at the indicated experimental time points following transplant of APs from the SWAT of leptin-luciferase; mTmG mice. (n = 12) (D) Representative image of VWAT depot with luminescent overlay showing the region with luciferase activity in the left pad where the transplant was performed. (E) Representative confocal images of the luminescent region in (D) showing tdTomato+ mature adipocytes with LipidTOX staining (yellow crosses) adjacent to endogenous tdTomato− adipocytes (white asterisks). Exposure time for each luminescent image was 1 minute. Scale bar is 100μM. Significance was determined using an unpaired two-tailed student’s t-test. Error bars represent mean ± S.E.M. See also Figure S4.

Comment in

Similar articles

Cited by

References

    1. Appleton SL, Seaborn CJ, Visvanathan R, Hill CL, Gill TK, Taylor AW, Adams RJ. Diabetes and cardiovascular disease outcomes in the metabolically healthy obese phenotype: a cohort study. Diabetes Care. 2013;36:2388–2394. - PMC - PubMed
    1. Arner P, Andersson DP, Thorne A, Wiren M, Hoffstedt J, Naslund E, Thorell A, Ryden M. Variations in the size of the major omentum are primarily determined by fat cell number. J Clin Endocrinol Metab. 2013;98:E897–901. - PubMed
    1. Baglioni S, Cantini G, Poli G, Francalanci M, Squecco R, Di Franco A, Borgogni E, Frontera S, Nesi G, Liotta F, et al. Functional differences in visceral and subcutaneous fat pads originate from differences in the adipose stem cell. PLoS One. 2012;7:e36569. - PMC - PubMed
    1. Barzilai N, She L, Liu BQ, Vuguin P, Cohen P, Wang J, Rossetti L. Surgical removal of visceral fat reverses hepatic insulin resistance. Diabetes. 1999;48:94–98. - PubMed
    1. Berry R, Jeffery E, Rodeheffer MS. Weighing in on adipocyte precursors. Cell Metab. 2014;19:8–20. - PMC - PubMed

Publication types